Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)

TipRanksApr 9 12:30

DBS: Maintaining the “Buy” Rating of Weigao Shares (01066.HK) and reducing the target price to HK$6.4

DBS released a research report stating that it maintained the “buy” rating of Weigao shares (01066.HK) and lowered the target price from HK$11.6 to HK$6.4.

Zhitong FinanceApr 8 14:26

Weigao Co., Ltd. (1066.HK): Performance under pressure due to collection and base figures

Guide to this report: In 2023, performance is under pressure due to the influence of collection and base figures. As the marginal impact of collection narrows and the base effect declines, it is expected that the normal growth rate will return to normal growth from 2024 and maintain the holding rating. Summary: Maintain an increase in holdings rating. contemplates

國泰君安Apr 7 14:26

Bank Rating | Goldman Sachs: Lowering the target price of Weigao shares to HK$8.7 to maintain a “buy” rating

Glonghui, April 3 | Goldman Sachs released a rating report stating that in the second half of last year, sales of Weigao shares fell 5% year-on-year to 6.3 billion yuan, and net profit fell 35% to 804 million yuan, in line with the earlier profit warning. Management proposed a 5% to 10% year-on-year increase for this year, slightly lower than expected, and raised the dividend ratio from 30% to 40%, considering the company's strong cash flow. The bank said it would adjust the company's earnings estimates per share for each year from 2024 to 26 to a decrease of 2.5%, a decrease of 0.4% and a decrease of 3%, respectively. The target price was lowered from HK$10 to HK$8.7, maintaining its rating as a “buy”.

Gelonghui FinanceApr 3 11:08

Weigao Co., Ltd. (01066.HK): 2023 results are in line with expectations and await a steady recovery in 2024

Weigao's performance is in line with our expectations for 2023: revenue of 13.2 billion yuan, a year-on-year decrease of 3.8%; a year-on-year increase of 1% after deducting products related to the epidemic during the same period; net profit to mother was 2 billion yuan, a year-on-year decrease of 27.6 billion yuan

中金公司Mar 29 08:11

WEIGAO GROUP To Go Ex-Dividend On June 3rd, 2024 With 0.10396 HKD Dividend Per Share

March 27th - $WEIGAO GROUP(01066.HK)$ is trading ex-dividend on June 3rd, 2024. Shareholders of record on June 4th, 2024 will receive 0.10396 HKD dividend per share on July 12th, 2024. The ex-divi

Futu NewsMar 27 17:05